← Leaderboards
Jesse Damsker
Reveragen Biopharma, Inc.
$1,130,321
Attributed
$1,331,841
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $450K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,331,841 · 6
By mechanism
R41$1,153,800 · 5
R43$178,041 · 1
Top collaborators
- Peter A Merkel1 shared
- Zenaide Maria Quezado1 shared
Most similar at Reveragen Biopharma, Inc.
Same institution · by research overlap
- Paula R Clemens$13,640,837
- Eric P Hoffman$47,884,792
- Zenaide Maria Quezado$112,500
Others in their field
Top investigators on “Muscular Dystrophies”
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$53,688,339
- Stephen J. Tapscott · Fred Hutchinson Cancer Center$24,320,230
- Elizabeth M McNally · University Of Chicago$24,290,327
- Eric P Hoffman · Reveragen Biopharma, Inc.$24,157,975
- Charles A Thornton · Virginia Commonwealth University$22,039,420
- Krista H Vandenborne · University Of Pennsylvania$21,082,899
Research focus
Muscular DystrophiesLeadPropertyTherapeutics For Rare And Neglected DiseasesSmall Business Technology Transfer ResearchGlucocorticoidsMouse ModelProgramsPublishingSteroidsPharmaceutical PreparationsAnalogAdverse EffectsAnti-InflammatoryAnti-Inflammatory AgentsInflammatoryPhase I Clinical TrialsPrednisoloneMediatingPublic Health RelevanceFundingOsteopeniaBlindedDisease Remission
Grant awards (6)
Building an evidentiary case for circulating GHBP as a biomarker for drug-associated stunting of growth$224,998
R41 · FY2018 · HD · contact PI
Establishing a biomarker framework for feasibility studies of vamorolone in vasculitis$178,041
R43 · FY2018 · AR · contact PI
Effectiveness of VBP15, a dissociative steroidal analogue, on chronic inflammation in a mouse model of multiple sclerosis$253,802
R41 · FY2016 · AI · contact PI
Effectiveness of VBP15, a dissociative steroidal analogue, on inflammation in a mouse model of arthritis$225,000
R41 · FY2015 · AR · contact PI
Evaluation of VBP15 a dissociative steroidal analogue on pain and inflammation$225,000
R41 · FY2014 · MD · contact PI
Effect of VBP15, a dissociative steroidal analogue, on intestinal epithelial repair processes in inflammatory bowel disease$225,000
R41 · FY2014 · DK · contact PI